Detalhe da pesquisa
1.
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).
Ann Oncol
; 29(8): 1853-1860, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982279
2.
DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.
Leukemia
; 31(3): 688-696, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748370